The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of ...

BDX collaborates with Waters in a $17.5B deal to form a diagnostics powerhouse targeting $9B in revenues by 2030.

BD and Waters announced an agreement to create a new life science and diagnostics leader through a business combination.

Waters Corporation is merging with BD’s Biosciences and Diagnostic Solutions business in a $17.5 billion deal to expand its capabilities in life sciences and diagnostics.

BD has found a new home for its biosciences and diagnostics divisions at the lab equipment maker Waters Corporation, through ...

Kirkland & Ellis advises Waters on $17.5B merger with Becton Dickinson, creating a diagnostics and life sciences leader.

Waters Corporation (WAT) stock downgraded at Wells Fargo based on execution risks related to its $17.5B M&A deal with a unit of Becton Dickinson (BDX). Read more here;.

Shares of Waters Corporation (NYSE:WAT) declined 2.2% following the announcement of a $17.5 billion Reverse Morris Trust deal ...

Waters said it reached a deal to buy the Biosciences & Diagnostic Solutions business of Becton Dickinson for around $17.5 ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Waters Corporation (NYSE: WAT) and BD and Company’s Biosciences & Diagnostic Solutions business is fair to Waters ...

Detailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations ...